drugset / Trial / NCT03579446
Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer
NaSingle-groupOpen-labelSupportive care
Summary
This early phase I trial studies how well levorphanol works as a second line opioid in reducing pain in patients with cancer that may have spread to other places in the body. Levorphanol may work better in controlling cancer pain.
Timeline
- Start
- 2018-11-29
- Primary completion
- 2023-06-15
- Completion
- 2023-06-15
Outcome
Outcome not reported
Stopped: “\<75% participation”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levorphanol | Small molecule | — | Oral |
| Background | Hydrocodone | Unknown | — | Oral |
| Background | Hydromorphone | Other / unclassified | — | Oral |
| Background | Morphine | Other / unclassified | — | Oral |
| Background | Oxycodone | Other / unclassified | — | Oral |
| Background | Oxymorphone | Small molecule | — | Oral |